Fisher & Paykel HealthcareFSPKF +9.59%90 Days Inventory is 139.58 as of Mar. 2026, which is 7% below its 10-year median of 149.78. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $25.98 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks better than 63.91% on this metric.
The historical rank and industry rank for Fisher & Paykel Healthcare's Days Inventory or its related term are showing as below:
FSPKF'
s Days Inventory Range Over the Past 10 Years
Min: 104.91 Med: 149.78 Max: 205.78
Current: 146.17
During the past 13 years, Fisher & Paykel Healthcare's highest Days Inventory was 205.78. The lowest was 104.91. And the median was 149.78.
FSPKF's Days Inventory is ranked better than 63.91% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.73
vs FSPKF: 146.17
Inventory Turnover measures how fast the company turns over its inventory within a year.
Fisher & Paykel Healthcare's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fisher & Paykel Healthcare's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.28.
Fisher & Paykel Healthcare (OTCPK:FSPKF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Fisher & Paykel Healthcare's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fisher & Paykel Healthcare's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Fisher & Paykel Healthcare Days Inventory Related Terms
Fisher & Paykel Healthcare Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FSPKF vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FSPKF) has a Days Inventory of 139.58 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fisher & Paykel Healthcare and its competitors. This is near median its historical median of 149.78. Over the past decade, Fisher & Paykel Healthcare's Days Inventory has ranged from 104.91 to 205.78. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #284 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 36.1%.
Is Fisher & Paykel Healthcare's Days Inventory too high?
Fisher & Paykel Healthcare's current Days Inventory of 139.58 is near median its 10-year median of 149.78. Over the past 10 years, this metric has ranged from a low of 104.91 to a high of 205.78. The Medical Devices & Instruments industry median Days Inventory is 179.73. Fisher & Paykel Healthcare's value of 139.58 is 22.3% below this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #284 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #284 out of 787 companies for Days Inventory. This puts Fisher & Paykel Healthcare in the upper half of its industry. The industry median Days Inventory is 179.73. Fisher & Paykel Healthcare's value of 139.58 is 22.3% below this benchmark. Historically, Fisher & Paykel Healthcare's own Days Inventory has ranged from 104.91 to 205.78 over the past decade. While the company's 10-year median is 149.78 vs. the industry median of 179.73, Fisher & Paykel Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.73, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Days Inventory of 139.58 is 22.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Days Inventory is 139.58, which is near median its own 10-year median of 149.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $25.98, compared to a current price of $22.52 — trading 13.3% below its estimated fair value. The current Days Inventory is 139.58, which is near median its 10-year median of 149.78 and 22.3% below the Medical Devices & Instruments industry median of 179.73. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current Days Inventory is 139.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of $22.52 is trading 13.3% below its estimated GF Value™ of $25.98.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for FSPKF:
Days Inventory: 139.58 (near median its 10-year median of 149.78)
GF Value™: $25.98 vs. price of $22.52 (13.3% below fair value)
Industry Position: 22.3% below the Medical Devices & Instruments median (#284 of 787)
No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score
Get the complete analysis for FSPKF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSPKF has been successfully added to your 
